|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Immunohistochemistry was combined with retrograde labeling to characterize the effect of respiratory infection with Sendai virus on the number of Substance P/Neurokinin A-containing vagal afferent neurons whose cell bodies resided in the nodose ganglia and whose receptive fields were located in guinea pig trachea. Of the neurons labeled from the trachea of vehicle-inoculated guinea pigs, few stained positively for Substance P/Neurokinin A (~ 3% of total labeled neurons). These neurons had small diameter cell bodies (mode = 16-20 µm), a feature of nociceptive-like C-fibers. Viral infection (Day 4 after inoculation) was associated with a significantly greater number of labeled neurons containing Substance P/Neurokinin A (~ 20% of total labeled neurons). The majority of these had a relatively large cell body diameter (mode = 36- 40 µm), a feature of nonnociceptive afferent neurons. This induction appeared to be reversible as there were significantly fewer Substance P/Neurokinin A positive neurons in nodose ganglia from virus-inoculated guinea pigs at Day 28 after inoculation, a time point when virus-induced airway inflammation had all but resolved. These findings support the hypothesis that viral infection leads to a qualitative change in the vagal afferent innervation of guinea pig airways such that both small diameter nociceptive-like neurons and large diameter nonnociceptive neurons express tachykinins.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: tachykinins; respiratory viral infection; airway innervation; sensory nerves; Substance P; Neurokinin A
Respiratory tract viral infections are frequently associated with exacerbations of asthma and increased responsiveness to tussive and bronchoconstricitve stimuli in otherwise healthy individuals (1-3). The mechanisms responsible for this remain uncertain but may involve virus-evoked airway inflammation, modulation of the immune response to allergen, and alterations in the efferent and afferent neural control of the airways (2, 4-6).
The airways of guinea pigs are innervated by phenotypically distinct groups of vagal afferent neurons whose cell bodies are located in the jugular (superior) or nodose (inferior)
vagal ganglia (7). Approximately one third of the vagal afferent neurons innervating the guinea pig trachea contain tachykinins such as Substance P (SP) and Neurokinin A (NKA) (7).
Unlike classic transmitters that are synthesized in nerve terminals, tachykinins are synthesized in neuronal cell bodies and
carried by axonal transport to the central and peripheral terminals of primary afferent neurons. Under normal conditions,
almost all of the tachykinergic fibers that innervate guinea pig
airways are derived from nociceptive-like neurons whose cell
bodies are located in the jugular ganglia (7). These tachykinin
containing nociceptive-like neurons have characteristic features that distinguish them from nonnociceptive afferent fibers. Compared with nonnociceptive fibers, tachykinin-containing nociceptive fibers typically have small cell bodies (less
than 25 µm in diameter) and axons that conduct action potentials in the C-fiber range (less than 1 m/second) (7-9). The terminals of these C-fibers in the airways are high-threshold
mechanosensors that respond vigorously to capsaicin and
bradykinin (7). In contrast, nonnociceptive fibers that innervate guinea pig airways have larger cell bodies (~ 30-50 µm in
diameter) that reside in the nodose ganglia. These neurons are
rapidly adapting low-threshold mechanosensors that conduct
action potentials in the A
-range (~ 5 m/second) (7-9) and
are thought to supply afferent input into the brain stem necessary to regulate normal breathing and resting bronchomotor
tone (10, 11).
The release of tachykinins from the peripheral terminals of nociceptive-like afferent fibers in the airways can activate neurokinin receptors in a variety of airway tissue and cell types, leading to alterations in bronchomotor tone, mucus secretion, and neurogenic inflammation (12). Respiratory infections are associated with increased levels of tachykinins in the airways (13) and are known to intensify tachykinin-evoked responses (14, 15). This appears to be at least partially due to decreased activity of neutral endopeptidase (16-18), a protease normally present within the airways that degrades tachykinins. There is accumulating evidence that irritation and inflammation of the airways is associated with the induction of tachykinin synthesis in airway afferent fibers (19). The aim of the current study was to investigate the possibility that nodose afferent neurons could be induced to express tachykinins during respiratory tract viral infection. Our findings indicate that respiratory viral infection in guinea pigs induces the expression of tachykinins in airway afferent neurons. Further, the data support the hypothesis that viral infection leads to a qualitative change in the vagal afferent innervation of the airways such that both small diameter nociceptive-like neurons and large diameter nonnociceptive neurons express tachykinins.
| |
METHODS |
|---|
|
|
|---|
Male guinea pigs (150 to 250 g; Harlan Sprague-Dawley Inc., Indianapolis, IN) were used to study the effect of respiratory tract infection with Parainfluenzia Type 1 (Sendai Virus, ATCC VR-105; American Type Culture Collection, Rockville, MD) on the percentage of retrogradely labeled airway afferent nodose neuron cell bodies immunoreactive (ir) for SP/NKA. Full details of the methods can be accessed in the online data supplement.
Airway vagal afferent neurons were retrogradely labeled by instillation of the fluorescent dye fast blue into the upper trachea of anesthetized (ketamine hydrochloride, 50 mg/kg intraperitoneally; xylazine hydrochloride, 2.5 mg/kg intraperitoneally) guinea pigs. We have
previously reported that dye instilled using this technique is limited to
the rostral region of the trachea (8). Seven days after retrograde labeling of tracheal afferent neurons, guinea pigs were anesthetized (ketamine hydrochloride, 50 mg/kg intraperitoneally; xylazine hydrochloride, 2.5 mg/kg intraperitoneally) and inoculated intranasally with
0.5 ml of fluid containing either 5 × 10
5 tissue culture infective doses
of Sendai virus or vehicle (diluted allantoic fluid from embryonated
chicken eggs). At various days after inoculation, vehicle and virus-inoculated guinea pigs were killed by asphyxiation with CO2, exsanguinated, and their nodose ganglia were removed, fixed (2% paraformaldehyde, 15% saturated picric acid in 0.15 M phosphate buffer), and
frozen. Continuous serial cryostat sections (12-µm thick) of the nodose
ganglia were thaw-mounted on gelatin-coated coverslips and prepared
for estimation of neuronal cell body diameter and immunofluorescent
localization of immunoreactive
(ir
) tachykinins as previously described (8). The primary antibody used has 100% crossreactivity with
SP and 40% crossreactivity with NKA (rabbit antisubstance P; Peninsula Laboratories, Belmont, CA). The secondary antibody was a fluorescein isothiocyanate-labeled goat antirabbit IgG (Peninsula Laboratories).
Bronchoalveolar lavage of vehicle and virus-inoculated guinea pigs was performed essentially as previously described (20). Cells in collected lavage fluid were washed in 0.9% NaCl and a cytospin preparation (Shandon Centrifuge, Pittsburgh, PA) of the sample was differentially stained (Giemsa stain) and counted.
In vitro extracellular recording of action potentials from nodose vagal afferent nerve fibers that innervated the airways of vehicle or virus-inoculated guinea pigs was performed as previously described (7). Mechanically sensitive receptive fields were revealed when a burst of action potentials was recorded in response to von Frey filament stimulation of the airway mucosal surface. Conduction velocity and amplitude of the action potential were then compared with responses elicited by electrical stimulation of either the recurrent laryngeal or vagus nerve trunks to determine the trunk that supplied the fiber. Conduction velocities were calculated by electrically stimulating the receptive field and measuring the distance traveled along the nerve pathway divided by the time between the shock artifact and the recorded action potential. Mechanical responsiveness was assessed using a series of von Frey filaments to deliver forces of increasing strength to identified mechanically receptive fields. The force required to elicit half of the number of action potentials evoked in response to supramaximal mechanical stimulation was used as a measure of mechanical sensitivity. The vast majority of vagal afferent fibers that innervate the guinea pig trachea/bronchus are mechanically sensitive (7); thus, only mechanically sensitive neurons were studied, and these nerve fibers had little or no activity at rest. If spontaneous activity exceeded one action potential per second, the fiber was not studied further.
| |
RESULTS |
|---|
|
|
|---|
Retrograde Neuronal Tracing
Nodose neuron cell bodies were retrogradely labeled by instillation of fast blue into the trachea of guinea pigs 7 days before intranasal inoculation with Sendai virus or vehicle. A total of 663 labeled neuronal cell bodies were identified in nodose ganglia obtained from vehicle-inoculated guinea-pigs (n = 4) and a total of 478 labeled cell bodies were identified in nodose ganglia obtained from guinea pigs at 4 days after inoculation with Sendai virus (n = 4). Diameters of labeled nodose neuron cell bodies from both groups of animals were similarly distributed (Figure 1A).
|
Immunofluorescence for SP/NKA
Retrograde labeling in combination with immunofluorescence techniques was used to assess the expression of ir-SP/NKA in airway specific nodose ganglion cell bodies. Few (~ 3%) nodose neuron cell bodies labeled from the trachea of vehicle- inoculated guinea pigs (n = 4) stained positively for ir-SP/NKA (Figure 1B). In contrast, ~ 20% of cell bodies labeled from the trachea of virus-inoculated guinea pigs (Day 4 after inoculation; n = 4) stained positively for ir-SP/NKA (Figure 1B).
We estimated the diameters of ir-tachykinin-positive nodose neuron cell bodies labeled from the airways of vehicle and virus-inoculated guinea pigs. The few labeled nodose neuron cell bodies from vehicle-inoculated guinea pigs that did stain positively for ir-tachykinins had relatively small cell diameters (mode = 16-20 µm; Figure 1B). In contrast, the majority of ir-SP/NKA-positive nodose neurons that were labeled from the trachea of virus-inoculated guinea pigs (Day 4 after inoculation) had relatively large cell body diameters (mode = 36-40 µm; Figure 1B).
Time Course of Virus-induced Expression of ir-SP/NKA
Respiratory viral infections in guinea pig are associated with airway inflammation that develops over the first 2 days after inoculation, peaks within 3-4 days, and usually resolves within 3 weeks (20). Consistent with this time course, there were significantly fewer inflammatory cells in bronchoalveolar lavage fluid from virus-inoculated guinea pigs at Day 28 after inoculation compared with Day 4 after inoculation (data not shown).
To evaluate the time course of virus-induced changes of ir-tachykinin expression in nonnociceptive neurons, we estimated the percentage of large diameter (> 25 µm) ir-SP/ NKA-positive labeled nodose neuron cell bodies from vehicle and virus-inoculated animals at Day 1, Day 4, and Day 28 after inoculation. Consistent with the known time course of virus-induced airway inflammation, the number of large diameter labeled nodose neurons expressing ir-SP/NKA was significantly greater at Day 4 than at Day 1 or Day 28 after inoculation with virus (Figure 2).
|
Electrophysiologic Studies
In vitro extracellular recording was used to estimate the conduction velocity and mechanical sensitivity of vagal afferent fibers whose cell bodies resided in nodose ganglia and whose receptive fields were located in the trachea of control or virus-inoculated guinea pigs (Day 4 after inoculation). The conduction velocity of identified nodose fibers innervating the airways of control guinea pigs (4.4 ± 0.7 m/second, n = 4) was similar to that of nodose fibers innervating the airways of virus-inoculated guinea pigs (3.2 ± 0.8 m/second, n = 5). Nodose fiber receptive fields located in the guinea pig trachea/ bronchus are exquisitely sensitive to mechanical stimuli, to which they respond with a characteristic rapidly adapting pattern of action potential discharge (7, 21). Nodose fiber receptive fields in the trachea/bronchus of control or virus-inoculated guinea pigs were similarly sensitive to mechanical stimulation (Figure 3A), to which they responded with a characteristic rapidly adapting response (Figure 3B). The force required to evoke a half maximal response to mechanical stimulation of receptive fields in the tracheas of control guinea pigs was 180 ± 50 mg (n = four fibers from two guinea pigs), whereas that of virus-inoculated guinea pigs was 200 ± 30 mg (n = five fibers from three guinea pigs).
|
| |
DISCUSSION |
|---|
|
|
|---|
We found that respiratory infection with Sendai virus in guinea pigs is associated with the presence of ir-SP/NKA in a population of airway-specific, large-diameter nodose afferent neurons. Given their distinct physiologic characteristics, the induction of tachykinin expression in nodose neurons that innervate the airways may contribute to the abnormal physiology associated with respiratory viral infections.
Under normal conditions the vagal tachykinergic innervation of guinea pig airways is derived almost exclusively from
nociceptive-like C-fibers (22, 23), whose small diameter cell
bodies reside in the jugular ganglia (7, 9, 24). The nodose afferent fibers that specifically innervate guinea pig airways are
typically faster conducting A
-fibers, with characteristic large
diameter cell bodies and receptive fields in the airways that do
not respond to classic nociceptive fiber-selective stimuli such
as bradykinin and capsaicin (7, 9, 24). These fibers are exquisitely sensitive to mechanical stimuli, to which they respond
with a characteristic rapidly adapting pattern of action potential discharge (7, 21). The nodose fibers whose receptive fields
we identified in the airways of control and virus-inoculated
guinea pigs conducted action potentials in the A
range and
were similarly highly sensitive to punctate mechanical stimuli,
to which they responded with a rapidly adapting pattern of action potential discharge. Thus, respiratory viral infection did
not appear to overtly influence the general physiologic characteristics of nodose nerve endings in the airways.
Few (~ 3%) nodose neuron cell bodies labeled from the airways of vehicle-inoculated guinea pigs stained positively for tachykinins. In contrast, ~ 20% of nodose neuron cell bodies labeled from the airways of virus-inoculated guinea pigs (Day 4 after inoculation) stained positively for SP/NKA, suggesting that viral infection, like allergen-induced inflammation (24), is associated with the induction of tachykinin expression in nodose ganglion neurons. This induction appears to be reversible, as we found significantly fewer tachykinin-positive neurons in nodose ganglia from virus-infected guinea pigs at Day 28 after inoculation, a time point when virus-induced airway inflammation, assessed from bronchoalveolar lavage fluid, had all but resolved. An interesting finding of this study was that the majority nodose neuron cell bodies that contained ir-SP/NKA during viral infection had large diameters (> 25 µm), indicative of nonnociceptive neurons, whereas the few tachykinin-positive cell bodies from vehicle-inoculated guinea pigs had small diameters, indicative of nociceptive-like C-fibers. Thus, it would appear that although there were a few tachykinergic nodose fibers innervating the airways of vehicle-inoculated guinea pigs, they were probably nociceptive-like neurons; however, during viral infection, tachykinin expression was induced in a significant number of airway-specific nonnociceptive nodose fibers.
As visceral inflammation has been associated with an increase in the cell body diameter of afferent neurons located in dorsal root ganglia (25), an alternative interpretation of our data is that viral infection led to an increased cell body diameter of SP/NKA-expressing nociceptive neurons in the nodose ganglia. However, this hypothesis is unlikely to explain our findings, as only ~ 3% of the airway-specific nodose neurons in vehicle-inoculated animals had small diameter cell bodies; thus, even if all of these increased their diameter, it would not explain our observation that ir-SP/NKA was found in ~ 20% of the labeled nodose neurons during viral infection. In any case, we found that the frequency histogram of cell diameters of airway-specific neurons in the nodose ganglia was not different between virus and vehicle-inoculated guinea pigs. Thus, the more likely explanation for our findings is that viral infection induced the expression of tachykinins in a population of nodose neurons with large cell bodies.
The expression of tachykinins in large diameter nodose fibers during viral infection may be expected to impact airway
physiology. The release of tachykinins from the peripheral terminals of afferent C-fibers in the airways is known to result in
increased blood flow through the microvascular bed of the airways, increased microvascular permeability, and inflammatory cell recruitment, collectively know as neurogenic inflammation (12). Like nociceptive C-fibers in other tissues, airway
C-fibers are not thought to release tachykinins under normal
physiologic conditions, but rather do so only in response to
noxious stimuli. In sharp contrast, large diameter nodose A
-fibers that innervate guinea pig airways are low threshold mechanosensors (7) that may be active under normal conditions where they play a role in the reflex regulation of normal
breathing and resting airway caliber (10, 11). Thus, if the nodose A
-fibers that are induced to express tachykinins are
able to release these tachykinins from their peripheral terminal in the airways, nonnoxious stimuli sufficient to activate
A
-fibers may now evoke the release of tachykinins in the airways during viral infection. Respiratory infections are associated with enhanced responsiveness to tachykinins (14-16) and
increased levels of tachykinins in the airways (13) due, at least
in part, to decreased enzymatic degradation. Consistent with
this, the administration of neurokinin receptor antagonists to
guinea pigs can reduce virus-induced airway inflammation (26), although the neuronal source of the tachykinins responsible is unknown. Our current observations suggest that nonnociceptive nodose A
-fibers as well as nociceptive-like jugular C-fibers are potential sources of tachykinins in the airways during viral infection.
Although much less studied, tachykinin release from the
central terminals of primary afferent neurons in nucleus of the
solitary tract of the brain stem may have more influence on
airway physiology than tachykinin release from their peripheral terminals in the airway wall. In the somato-sensory system, tachykinins are released from the central terminals of
primary afferent neurons and act as neuromodulators to enhance the excitability of secondary neurons in the spinal cord,
thereby enhancing the perception of pain and/or reflex responses to noxious stimuli (27). Relatively little work has been
published on the mechanisms by which tachykinins modulate
vagal afferent neuronal input to the brain stem from the airways. Nevertheless, pharmacologic studies have demonstrated that the neurokinin receptors NK1, NK2, and NK3 are present
in secondary neurons within the nucleus of the solitary tract,
and stimulation of these receptors can profoundly affect airway reflex physiology (28, 29). Also consistent with a role for
tachykinins in modulating airway reflexes, the NK1 receptor-selective antagonist CP-99,994 and SR-48968, an NK2 receptor-selective antagonist, were able to inhibit mechanically-induced
cough in the guinea pig and cat by an action in the central nervous system (30). As tachykinin release in the brain stem may
enhance airway reflexes, inflammatory stimuli that lead to the
expression of tachykinins in low threshold nodose A
-fibers
that are active during normal breathing, may cause the release
of tachykinins from their central terminals, where they may alter airway afferent neuronal input into the brain stem.
The mechanism by which viral infection leads to the expression of tachykinins in large diameter nodose A
-fibers is
unknown, but may involve the neurotrophins, a family of peptides known to act on peripheral nerve endings, and send signals to their cell bodies contained in remotely located ganglia.
Potential cellular sources of neurotrophins in the airways include the respiratory epithelium, T lymphocytes, alveolar macrophages, and mast cells (31-33). Neurotrophins initiate their
effects in vagal afferent neurons, in part, by binding to high-affinity receptors of the tyrosine kinase family, followed by
uptake and retrograde transport to the cell body in the vagal
ganglia (34). Among the family of neurotrophins most attention has been given to nerve growth factor (NGF) as a potential mediator of neuronal plasticity in inflamed airways. NGF
is found in human airways and the NGF content of airway lavage fluid is increased after allergen challenge (31, 35, 36). NGF is
capable of stimulating the expression of mRNAs encoding the
precursors of SP and calcitonin gene-related peptide in mature
afferent neurons (37). Moreover, instillation of NGF into the
trachea of guinea pigs was associated with a greater percentage of large diameter airway-specific afferent neurons that express ir-SP (9). Combined, these findings are consistent with
the hypothesis that neurotrophins may contribute to tachykinin expression is airway specific large diameter nodose ganglion neurons during viral infection.
In summary, the major finding of this study was that respiratory infection of guinea pigs with Sendai virus is associated with the expression of ir-SP/NKA in a population of vagal afferent neurons whose large diameter cell bodies reside in the nodose ganglia. The data support the hypothesis that these neurons project low-threshold nonnociceptive fibers to the airways. This sets up a potential condition in which the release of tachykinins from the peripheral and central terminals of airway afferent nerves could occur independently of nociceptive C-fiber stimulation.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Bradley J. Undem, The Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224. E-mail: bundem{at}jhmi.edu
(Received in original form August 14, 2001 and accepted in revised form November 19, 2001).
Funded by a grant from The Heart, Lung and Blood Institute of the National Institutes of Health, Bethesda, MD.| |
References |
|---|
|
|
|---|
1. Aquilina AT, Hall WJ, Douglas RG Jr,, Utell MJ. Airway reactivity in subjects with viral upper respiratory tract infections: the effects of exercise and cold air. Am Rev Respir Dis 1980; 122: 3-10 [Medline].
2. Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976; 113: 131-139 [Medline].
3. Lemanske RF Jr,, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989; 83: 1-10 .
4. Corne JM, Holgate ST. Mechanisms of virus induced exacerbations of asthma. Thorax 1997; 52: 380-389 [Medline].
5. Fryer AD, Jacoby DB. Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 1991; 102: 267-271 [Medline].
6. Gern JE, Busse WW. The effects of rhinovirus infections on allergic airway responses. Am J Respir Crit Care Med 1995; 152: S40-S45 .
7. Riccio MM, Kummer W, Biglari B, Myers AC, Undem BJ. Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways. J Physiol (Lond) 1996; 496: 521-530 [Medline].
8.
Hunter DD,
Undem BJ.
Identification and substance P content of vagal
afferent neurons innervating the epithelium of the guinea pig trachea.
Am J Respir Crit Care Med
1999;
159:
1943-1948
9.
Hunter DD,
Myers AC,
Undem BJ.
Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons.
Am J Respir Crit
Care Med
2000;
161:
1985-1990
10.
Kesler BS,
Canning BJ.
Regulation of baseline cholinergic tone in
guinea-pig airway smooth muscle.
J Physiol
1999;
518:
843-855
11. Jordan D. Central nervous pathways and control of the airways. Respir Physiol 2001; 125: 67-81 [Medline].
12.
Lundberg JM.
Tachykinins, sensory nerves, and asthma
an overview.
Can J Physiol Pharmacol
1995;
73:
908-914
[Medline].
13.
Tripp RA,
Moore D,
Winter J,
Anderson LJ.
Respiratory syncytial virus
infection and G and/or SH protein expression contribute to substance
P, which mediates inflammation and enhanced pulmonary disease in
BALB/c mice.
J Virol
2000;
74:
1614-1622
14. Saban R, Dick EC, Fishleder RI, Buckner CK. Enhancement by parainfluenza 3 infection of contractile responses to substance P and capsaicin in airway smooth muscle from the guinea pig. Am Rev Respir Dis 1987; 136: 586-591 [Medline].
15.
Yamawaki I,
Geppetti P,
Bertrand C,
Chan B,
Massion P,
Piedimonte G,
Nadel JA.
Viral infection potentiates the increase in airway blood
flow produced by substance P.
J Appl Physiol
1995;
79:
398-404
16.
Dusser DJ,
Jacoby DB,
Djokic TD,
Rubinstein I,
Borson DB,
Nadel JA.
Virus induces airway hyperresponsiveness to tachykinins: role of neutral endopeptidase.
J Appl Physiol
1989;
67:
1504-1511
17.
Borson DB,
Brokaw JJ,
Sekizawa K,
McDonald DM,
Nadel JA.
Neutral
endopeptidase and neurogenic inflammation in rats with respiratory
infections.
J Appl Physiol
1989;
66:
2653-2658
18.
Jacoby DB,
Tamaoki J,
Borson DB,
Nadel JA.
Influenza infection causes
airway hyperresponsiveness by decreasing enkephalinase.
J Appl Physiol
1988;
64:
2653-2658
19. Carr MJ, Undem BJ. Inflammation-induced placiticity of the afferent innervation of the airways. Environ Health Perspect 2001; 109: 567-571 .
20. Folkerts G, Van Esch B, Janssen M, Nijkamp FP. Virus-induced airway hyperresponsiveness in guinea pigs in vivo: study of broncho-alveolar cell number and activity. Eur J Pharmacol 1992; 228: 219-227 [Medline].
21.
McAlexander MA,
Myers AC,
Undem BJ.
Adaptation of guinea-pig vagal airway afferent neurones to mechanical stimulation.
J Physiol
1999;
521:
239-247
22. Saria A, Martling CR, Dalsgaard CJ, Lundberg JM. Evidence for substance P-immunoreactive spinal afferents that mediate bronchoconstriction. Acta Physiol Scand 1985; 125: 407-414 [Medline].
23. Kummer W, Fischer A, Kurkowski R, Heym C. The sensory and sympathetic innervation of guinea-pig lung and trachea as studied by retrograde neuronal tracing and double-labelling immunohistochemistry. Neuroscience 1992; 49: 715-737 [Medline].
24. Fischer A, McGregor GP, Saria A, Philippin B, Kummer W. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest 1996; 98: 2284-2291 [Medline].
25.
Yoshimura N,
de Groat WC.
Increased excitability of afferent neurons
innervating rat urinary bladder after chronic bladder inflammation.
J
Neurosci
1999;
19:
4644-4653
26.
Jacoby DB,
Yost BL,
Elwood T,
Fryer AD.
Effects of neurokinin receptor antagonists in virus-infected airways.
Am J Physiol Lung Cell Mol
Physiol
2000;
279:
L59-65
27.
Woolf CJ,
Salter MW.
Neuronal plasticity: increasing the gain in pain.
Science
2000;
288:
1765-1769
28.
Mutoh T,
Bonham AC,
Joad JP.
Substance P in the nucleus of the solitary tract augments bronchopulmonary C fiber reflex output.
Am J
Physiol Regul Integr Comp Physiol
2000;
279:
R1215-R1223
.
29. Mazzone SB, Geraghty DP. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists. Br J Pharmacol 2000; 129: 1121-1131 [Medline].
30. Bolser DC, DeGennaro FC, O'Reilly S, McLeod RL, Hey JA. Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat. Br J Pharmacol 1997; 121: 165-170 [Medline].
31. Braun A, Lommatzsch M, Lewin GR, Virchow JC, Renz H. Neurotrophins: a link between airway inflammation and airway smooth muscle contractility in asthma? Int Arch Allergy Immunol 1999; 118: 163-165 [Medline].
32.
Braun A,
Lommatzsch M,
Mannsfeldt A,
Neuhaus-Steinmetz U,
Fischer A,
Schnoy N,
Lewin GR,
Renz H.
Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic
inflammation.
Am J Respir Cell Mol Biol
1999;
21:
537-546
33. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, Levi-Montalcini R. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994;91:3739-3743.
34. Helke CJ, Adryan KM, Fedorowicz J, Zhuo H, Park JS, Curtis R, Radley HE, Distefano PS. Axonal transport of neurotrophins by visceral afferent and efferent neurons of the vagus nerve of the rat. J Comp Neurol 1998; 393: 102-117 [Medline].
35.
Virchow JC,
Julius P,
Lommatzsch M,
Luttmann W,
Renz H,
Braun A.
Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation.
Am J Respir Crit Care Med
1998;
158:
2002-2005
36. Undem BJ, Riccio MM. Activation of airway afferent nerves. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ, editors. Asthma. Philadelphia: Lippincott-Raven; 1997. p. 1009-1025.
37. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989; 337: 362-364 [Medline].
This article has been cited by other articles:
![]() |
L.P.A. McGarvey, L. Polley, and J. MacMahon Review Series: Chronic cough: Common causes and current guidelines Chronic Respiratory Disease, November 1, 2007; 4(4): 215 - 223. [Abstract] [PDF] |
||||
![]() |
K. Chung Review Series: Chronic cough: Future directions in chronic cough: mechanisms and antitussives Chronic Respiratory Disease, August 1, 2007; 4(3): 159 - 165. [Abstract] [PDF] |
||||
![]() |
T. Taylor-Clark and B. J. Undem Transduction mechanisms in airway sensory nerves J Appl Physiol, September 1, 2006; 101(3): 950 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Undem and M. Kollarik The Role of Vagal Afferent Nerves in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 355 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Wilfong and R. D. Dey Nerve Growth Factor and Substance P Regulation in Nasal Sensory Neurons after Toluene Diisocyanate Exposure Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Undem, B. Chuaychoo, M.-G. Lee, D. Weinreich, A. C. Myers, and M. Kollarik Subtypes of vagal afferent C-fibres in guinea-pig lungs J. Physiol., May 1, 2004; 556(3): 905 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Joad, P. A. Munch, J. M. Bric, S. J. Evans, K. E. Pinkerton, C.-Y. Chen, and A. C. Bonham Passive Smoke Effects on Cough and Airways in Young Guinea Pigs: Role of Brainstem Substance P Am. J. Respir. Crit. Care Med., February 15, 2004; 169(4): 499 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Jacoby Airway Neural Plasticity: The Nerves They Are A-Changin' Am. J. Respir. Cell Mol. Biol., February 1, 2003; 28(2): 138 - 141. [Full Text] [PDF] |
||||
![]() |
M. J. Tobin Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 319 - 332. [Full Text] [PDF] |
||||
![]() |
K. N. Browning and D. Mendelowitz Musings on the Wanderer: What's New in Our Understanding of Vago-Vagal Reflexes?: II. Integration of afferent signaling from the viscera by the nodose ganglia Am J Physiol Gastrointest Liver Physiol, January 1, 2003; 284(1): G8 - G14. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Lamb and M. P. Sparrow Three-Dimensional Mapping of Sensory Innervation with Substance P in Porcine Bronchial Mucosa: Comparison with Human Airways Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1269 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Fryer and D. B. Jacoby Plasticity of cholinergic and tachykinergic nerves: the convergence of the twain Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L907 - L908. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |